Crossmark

The implementation status of prehabilitation during neoadjuvant chemotherapy for patients with locally advanced esophageal cancer: a questionnaire survey to the board-certified facilities in Japan

Crossref DOI link: https://doi.org/10.1007/s10388-024-01075-7

Published Online: 2024-07-24

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Harada, Tsuyoshi https://orcid.org/0000-0003-4459-8262
Tsuji, Tetsuya

Fukushima, Takuya

Ikeda, Tomohiro

Toyama, Shusuke

Konishi, Nobuko

Nakajima, Hiroki

Suzuki, Katsuyoshi

Matsumori, Keiji

Yanagisawa, Takumi

Hashimoto, Kakeru

Kagaya, Hitoshi

Zenda, Sadamoto

Kojima, Takashi

Fujita, Takeo

Ueno, Junya

Hijikata, Nanako

Ishikawa, Aiko

Hayashi, Ryuichi
License Information

Text and Data Mining valid from 2024-07-24

Version of Record valid from 2024-07-24
More Information

Article History

Received: 7 May 2024

Accepted: 18 July 2024

First Online: 24 July 2024

Declarations

:

: This study was approved by the Research Ethics Committee of the National Cancer Center (2023-135) and the Shizuoka Cancer Center (T2023-25-2023-1-3) in accordance with the Declaration of Helsinki. All of the participants received verbal and written explanations regarding study procedures and signed an informed consent form upon agreement to participate.

: All authors declare no potential conflicts of interest with regard to the research, authorship, or publication of this article.

Document is current

Any future updates will be listed below